Novo Nordisk says CagriSema outperforms semaglutide in late-stage trial of type-2 diabetes patientsreuters.com
Current Chemicals Launches as Independent Specialty Materials Manufacturer, Building on 75-Year GE Legacy with Backing from Momentum Global Venturesbusinesswire.com
Cleveland-Cliffs (CLF) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Releasezacks.com
Cincinnati Financial (CINF) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Releasezacks.com